Lv01
0 积分 2026-03-23 加入
Good outcome with trimethoprim 10 mg/kg/day-sulfamethoxazole 50 mg/kg/day for Pneumocystis jirovecii pneumonia in HIV infected patients
7小时前
已完结
Underlying renal insufficiency: the pivotal risk factor for Pneumocystis jirovecii pneumonia in immunosuppressed patients with non-transplant glomerular disease
7小时前
已完结
Incidence of Hyponatremia with High-Dose Trimethoprim-Sulfamethoxazole Exposure
7小时前
求助中
The risk factor analysis and treatment experience in pneumocystis jirovecii pneumonia after kidney transplantation
7小时前
已完结
Development and validation of an instrument to measure the postgraduate clinical learning and teaching educational environment for hospital-based junior doctors in the UK
22天前
已完结
Paediatric excipient risk assessment (PERA) tool and application for selecting appropriate excipients for paediatric dosage forms – Part 2
3个月前
已关闭
Paediatric excipient risk assessment (PERA) tool and application for selecting appropriate excipients for paediatric dosage forms – Part 2
3个月前
已关闭
Selecting appropriate excipients for paediatric dosage form − Paediatric excipients risk assessment (PERA) framework – Part 1
3个月前
已完结
Decoding fatal toxic effects in checkpoint inhibitor therapy using real‐world pharmacovigilance data and machine learning
3个月前
已完结
皖公网安备34019202002308
